Trials / Sponsors / Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals Corporation
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study to Evaluate the Effects of Tempol (MBM-02) in COVID-19 Patients. Covid19 | Phase 2 / Phase 3 | 2021-09-01 |
| Withdrawn | Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma Asthma | Phase 3 | 2019-02-01 |
| Withdrawn | Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Persistent Asthma Asthma | Phase 3 | 2019-02-01 |
| Unknown | Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer Prostate Cancer | Phase 1 / Phase 2 | 2011-08-01 |